Introduction:
In recent decades the emphasis on developing systems to measure the severity of illness in the intensive care units (ICUs) has increased. Several models have been made for mortality prediction in critically ill patients 1, 2 . By using these indices, in addition to making decisions about the cost effectiveness of these services 3, 4 and assess the performance of different ICUs 5 , evaluation of the results of new treatments and technologies is also possible.
The main reasons that augmented the importance of these scoring systems are: 1-the scoring systems are used in clinical trials for matching, 2-these systems are used to quantify the severity of illness for the administrative decisions such as resource allocation, 3-the scoring systems assess the ICU performance, and compare the quality of care; and 4-they are used to appraise the prognosis of individual patients 6 .
The APACHE II and SAPS II systems can be used to calculate the individual risk of hospital death by converting the score into probability of death using logistic regression. Acute Physiology and Chronic Health Evaluation (APACHE) II and Simplified Acute Physiology Score (SAPS) II measure severity of illness by a numeric score based on physiologic variables selected because of their impact on mortality: the sicker the patient, the more deranged the values and the higher the score. The numeric scores are then converted into predicted mortality by using a logistic regression formula developed and validated on populations of ICU patients.
One interesting characteristics of APACHE II and SAPS II is that they propose to create homogeneous patients' categories from an inhomogeneous patients' case mix. These models try to avoid patient selection bias by including consecutive admission to the ICU in the development database. However one cannot exclude that some specific patient diagnoses have more weight than other and hence influence the outcome prediction. In addition, these models exclude some subgroups from analysis.
A variety of statistical methods are used to compare predictions with actual outcomes. Two principal considerations, namely, discrimination and calibration, should be taken into account during the validation process of a scoring system. Discrimination defines how well the model discriminates between patients who are likely to either die or not die; calibration refers to the correlation between the predicted and the actual outcome for the entire range of risk. The discriminating ability of the model can often be expressed by the area under the ROC curve. As this area approaches 1.0, the model becomes more 'perfect'; as the performance of the model becomes more random, the area under the curve trends towards 0.5. Calibration of the scoring system is often assessed by the use of Lemeshow and Hosmer's goodness-of-fit statistics.
Both systems have been evaluated in many population samples individually, in comparison to each other, or in comparison to other scoring systems. Their accuracy and predictive ability have also been tested in subgroups of critically ill patients, such as patients experiencing surgery, head trauma, and myocardial infarction. Using the severity of illness scoring systems has not been common in the Bangladeshi ICUs. In this study we evaluated the performance of two scoring systems: APACHE II and SAPS II on a sample of Bangladeshi patients in the ICUs of a postgraduate and referral hospitals in Dhaka.
Materials and Methods:
The research design of this study was non-experimental, a descriptive comparative prospective cohort study. The main purpose was to describe the performance of APACHE II and SAPS II to predict the probability of mortality in a well defined ICU patient cohort in Bangladesh.
We identified all individuals over 16 years old that had been admitted to the ICU at BIRDEM Hospital in January to December 2008 and at Ibn Sina Hospital ICU in October to December 2008. A total of 264 ICU admissions were identified in BIRDEM hospital and 64 admissions in Ibn Sina Hospital; however, we included only first-time ICU admissions, and did not include coronary care patients and cardiac surgery or other patients admitted for planned post-operative observations for less than 24 hours as defined in the original models. In addition, we excluded patients who had been readmitted to the ICU, during the same hospital stay. Every recurrent admission with a defined outcome of last hospitalization (e.g., discharge) was recorded as a separate ICU entry. Thus, total 194 patients were analyzed further. Because some of the clinical data were obtained from medical records, we confirmed that all the selected ICU patients had been in the ICU during the study period.
The authors used the APACHE II and SAPS II variables specified in their original publications to prepare the formal research instrument. All data regarding the variables were collected manually by the author himself. Enrolled patients under study were screened with respect to their demographic profile (age and sex), presence of chronic disease, past history of hospitalization and ICU admission, surgical status (elective or emergency surgery), major reason for ICU admission (i.e., predominant diagnostic category) and severity of illness (acute physiologic state). Initial and worst values were taken during the patient's first 24 h of ICU admission in respect of 12 variables constituting the acute physiology score (A). However, points were allocated to the worst values as per protocol of APACHE II scoring system. Age (B) and chronic disease (C) were also assigned points in similar manner. Sum of A, B and C constituted APACHE II score for a patient, derivation of which facilitated the subsequent calculation of predicted risk of mortality. In sedated patients, the Glasgow Coma Score (GCS) was determined either from medical records before sedation or through interviewing the physician who ordered the sedation. However, if a variable could not be measured the GCS was assumed normal. ICU stay, hospital length of stay (LOS) and lead time (the interval from hospital admission to ICU admission) were recorded. Patients were followed up until ICU and hospital discharge in order to registrar their survival status.
Statistical Analysis
Predicted mortality for APACHE II and SAPS II was calculated for each individual using the calculative software available free in the internet. SPSS v12 was used for statistical analysis.
In this study, categorical data were presented as n (%) and continuous data as mean±SD. Chi-square statistics were used to test for the statistical significance of category variables. All statistical tests were two-sided, and a significance level of 0.05 was used.
Validation of the systems was tested by assessing calibration and discrimination. Calibration (the ability to provide risk estimate corresponding to the observed mortality) was assessed by calibration curves and the Lemeshow-Hosmer goodness of fit C-statistic. Calibration curves were drawn by plotting predicted against actual mortality for groups of the patient population stratified by 10% increments of predicted mortality. To calculate the Cstatistic, the study population was stratified into ten deciles with approximately equal numbers of patients. The predicted and actual number of survivors and nonsurvivors were compared statistically with the use of formal goodness-of-fit testing to determine whether or not the discrepancy was statistically insignificant (P > 0.05). Lower Hosmer-Lemeshow x2 values and higher P-values (>0.05) indicate good fit. Model discrimination, defined as the ability of the model to discriminate in-hospital nonsurvivors from survivors, was assessed using the receiver operating characteristic (ROC) area under the curve (aROC) and 95% confidence interval. Figure 2 . There is no significant difference between survivor and non-survivor ICU patients in admission type in APACHE II and SAPS II score. 
Results

: Admission type in SAPS II
The APACHE II and SAPS II model exhibited good calibration ( = 8.304, p = 0.40 for APACHE II, = 9.040, p = 0.34 for SAPS II). Hosmer-Lemeshow goodness-of-fit test revealed a good performance for APACHE II and SAPS II scores. There was no significant difference between observed and expected values of the predicted mortality which suggests that the results of this study reveals good intensive care quality.
Discussion
In the present study, we evaluated the ability and validity of APACHE II and SAPS II systems to accurately predict hospital mortality in a Bangladeshi adult mixed-case ICU. Both models showed good discrimination and calibration. Intermodel comparison showed that both the models perform equally, although a slightly better performance was found with APACHE II.
These models have been broadly used in European and North American countries with a good reported performance. However, some care must be exercised in the interpretation of this calibration test as it is sensitive to the sample size. Significant Hosmer-Lemeshow goodnessof-fit chi-square statistics could be achieved only with increasing sample size of the population despite an excellent fit. However, calibration statistics were less accurate (Higher H and C values) in our study compared with those reported in the European/north American studies, because of the fact that larger cohorts of ICU patients were included in the western databases.
Various reasons might be considered to explain the problem of calibration of the tested models in our ICU patients. The overall discriminatory capability, as measured by the aROC, was generally good for two models and ranged from 0.78 to 0.89. APACHE II is slightly better compared to SAPS II score but not significantly better than SAPS II. These reasons include actual differences in the quality of care between Bangladeshi and western ICUs, or the consequences of other factors such as differences in the disease leading to ICU admission, lead time bias, or availability of resources.
Both models showed excellent discrimination, although the authors found that discrimination was better for APACHE II than for SAPS II. Good discrimination of both models has been reported in previous studies 7, 8, 9, [10] [11] [12] .
The area under the ROC of both systems was similar with the original reports. The reliability of the data collected is important because poor data can influence the predictions of mortality. Holt et al 19 showed that the main causes of data error in scoring APACHE II are inconsistent choice between highest and lowest value of acute physiologic score and GCS. The variability of GCS determination in sedated patients may affect the predicted death in both models. In the present study, the authors used the pre-sedation GCS in sedated patients as in previous studies 8 , an approach which has been shown to be associated with better performance of APACHE II than the approach that is normal GCS for sedated patients 20 . Systematic differences in medical definitions and inclusion criterias in the databases can also lead to calibration problems. However, all the definitions used in our study were in agreement with their original publications. Coronary care and post-cardiac surgical patients were not included in the present study.
The potential role of difference in case mix between the presented database and the development database may have had a negative impact of calibration assessment. In general, medical patients have a higher mortality risk than postoperative surgical patients, and in the present study population, medical patients constituted a larger proportion (89.2%) than in the original SAPS II database (48%) 17 . These differences in case mix could contribute to predicted death for the APACHE II and SAPS II model in the presented patients.
Lead time bias is another factor that could adversely affect the accuracy of risk prediction. Tunnell et al 18 revealed that lead time bias increased the APACHE II and SAPS II scores by 14 and 23 points, respectively, leading to the APACHE II and SAPS II prediction of hospital mortality being increased as much as 42.7% and 33.4%, respectively. Lead time bias occurs when patients are partially treated before ICU admission. Doing so would underestimate the severity of underlying disease. This factor is difficult to quantify in our study, but we can assume that most of our patients admitted to the Emergency department were transferred to the ICU without significant vital support since intensive care facilities are limited there. The lead time was no different between survivors and nonsurvivors. Thus, the authors believed that the influence of lead time bias on calibrations of both models is minimal in the present study.
The likelihood of some management deficiencies in our ICUs with the consequent higher observed over expected mortality is another issue to consider. It could argued that Bangladeshi ICUs do not have the same quality of care compared with western ICUs. Both models give very similar predicted probabilities of death (35% to 37%), while the actual mortality is 42%, suggests that there are probably some shortcomings in the quality of care in our ICUs. In a study comparing a French ICU with a Tunisian ICU, it was found that death rates were similar in both ICUs for diseases with extremes of predicted risks, while in midrange severity diseases, Tunisian patients had a higher death rate. Technology availability and the level of therapy, as assessed by omega scores, did not seem to explain these differences.
Conclusion:
Based on our findings, we are unable to show a significant superiority of one scoring system over another as both models performed equally in our ICU patients. However, we believe that even without proper calibration, these models could still be used in Bangladeshi ICUs. These models would be accurate enough for a general description of our ICU patients; they also could be used for comparison of Bangladeshi ICUs to each other and to stratify patients by level of severity for national therapeutic trials. However, to support clinical decisions, these models require an appropriate adjustment to reflect more precisely the mortality in our own ICU patients. It would be possible to customize actual models as it was performed with SAPS II in specific groups of patients with sepsis. There is no doubt, however, that even when well calibrated, the resulting new versions or "customized" models must be used as a supplement, rather than a substitute for good clinical judgment.
Although generalizing our results to all Bangladeshi ICUs would be hazardous, we believe that our study population represents a reliable reflection of our specific conditions. However, we need further prospective validation studies on a larger Bangladeshi ICU population before a firm conclusion.
